NW CORPORATE RESULTS | Dollar figures in thousands, except per share; parentheses denote losses. CombiMatrix Bioinformatics Dec. 31 % 4th QTR...

Share story

Dollar figures in thousands, except per share; parentheses denote losses.

CombiMatrix
Bioinformatics
Dec. 31 %
4th QTR 2007 2006 CHG
Profit ($3,458) ($4,503) +23.2
Per share (0.58)
Revenues 1,875 859 +118
ANNUAL 2007 2006 CHG
Profit ($12,553) ($19,961) +37.1
Per share (2.10)
Revenues 6,029 5,740 +5.0
COMMENT: The Mukilteo company, a recent spinoff of Acacia Research, saw its losses narrow on higher quarterly revenue due to Department of Defense contracts and sales of diagnostic services.
Flow International
Ultrahigh-pressure water-jet tools
Jan. 31 %
3rd QTR 2008 2007 CHG
Profit $5,897 $2,029 +191
Per share 0.16 0.05 +220
Sales 66,271 56,038 +18.3
9 MOS 2008 2007 CHG
Profit $8,569 $6,813 +25.8
Per share 0.23 0.18 +27.8
Sales 184,111 163,851 +12.4
COMMENT: The Kent company held the line on operating expenses in the fiscal third quarter, allowing more sales growth to flow to the bottom line. European and South American sales rose 34 percent; sales in North America, Flow’s biggest market, grew 18 percent. Last month, the Federal Trade Commission asked Flow for more information related to its proposed purchase of Omax, a similar company also in Kent. Flow said it’s cooperating and still expects the deal to go through.
Microvision
Miniature imaging systems
Dec. 31 %
4th QTR 2007 2006 CHG
Profit ($6,022) ($8,681) +30.6
Per share (0.11) (0.21) +47.6
Sales 2,988 1,842 +62.2
ANNUAL 2007 2006 CHG
Profit ($19,787) ($27,257) +27.4
Per share (0.40) (0.81) +50.6
Sales 10,484 7,043 +48.9
COMMENT: The Redmond developer of miniature display equipment and other light-scanning technologies got most of its 2007 revenue from contract work, but it concentrated its energies on getting its PicoP display engine to market. The goal is to launch the first PicoP-based consumer product by the end of the year.
Northstar Neuroscience
Biomedical equipment
Dec. 31 %
4th QTR 2007 2006 CHG
Profit ($4,857) ($5,272) +7.9
Per share (0.19) (0.21) +9.5
Revenue 1,150 1,435 -19.9
ANNUAL 2007 2006 CHG
Profit ($23,853) ($27,145) +12.1
Per share (0.92) (1.54) +40.3
Revenue 5,010 3,287 +52.4
COMMENT: The Seattle company’s quarterly loss narrowed on lower clinical-trial spending. The firm said Thursday it plans to emphasize its clinical program on treating depression through cortical stimulation.